Progress, Pitfalls, and Impact of AI ‐Driven Clinical Trials
Clinical Pharmacology & Therapeutics · 2025-04 · 117 (4) · 887-890
DOI: 10.1002/cpt.3542 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Pharmacology & Therapeutics, online erschienen am 25.12.2024. Verfasst von Dominika Wilczok und 1 weiteren Autor:innen. Beteiligte Einrichtung: Duke University, Durham, North Carolina, USA. Hauptthemen laut MEDLINE: Artificial Intelligence, Clinical Trials as Topic, Drug Discovery, Drug Development. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Since the deep learning revolution of the early 2010s, significant efforts and billions of dollars have been invested in applying artificial intelligence (AI) to drug discovery and development (AIDD). However, despite high expectations, few AI‐discovered or AI‐designed drugs have entered human clinical trials, and none have achieved clinical approval. In this perspective, we examine the challenges impeding progress and highlight opportunities to harness AI's potential in transforming drug discovery and development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Duke University, Durham, North Carolina, USA.
- Insilico Medicine US Inc, Cambridge, Massachusetts, USA.
- Insilico Medicine AI Ltd, Abu Dhabi, UAE.
- Insilico Medicine Hong Kong Ltd, Hong Kong, SAR, China.
ORCID-Profile: Dominika Wilczok, Alex Zhavoronkov
Zitieren
APA
Wilczok, D., & Zhavoronkov, A. (2025). Progress, Pitfalls, and Impact of AI ‐Driven Clinical Trials. Clinical Pharmacology & Therapeutics, 117(4), 887-890. https://doi.org/10.1002/cpt.3542
Vancouver
Wilczok D, Zhavoronkov A. Progress, Pitfalls, and Impact of AI ‐Driven Clinical Trials. Clinical Pharmacology & Therapeutics. 2025;117(4):887-890. doi:10.1002/cpt.3542
BibTeX
@article{Wilczok2025,
author = {Wilczok, Dominika and Zhavoronkov, Alex},
title = {Progress, Pitfalls, and Impact of AI ‐Driven Clinical Trials},
journal = {Clinical Pharmacology & Therapeutics},
year = {2025},
volume = {117},
number = {4},
pages = {887--890},
doi = {10.1002/cpt.3542}
}
EUVIMED